CENTRAL NERVOUS SYSTEM DYSFUNCTION AND THE ASSOCIATION WITH HSP70 ACTIVATION IN EXPERIMENTAL TOXIC HEPATITIS
Аннотация
Currently, drug-induced liver injury (DILI) remains one of the major challenges of modern medicine due to the widespread use of medications, the increasing prevalence of combination therapies, and the growing practice of self-medication without medical supervision. DILI may range from mild subclinical elevations of liver enzymes to severe acute liver failure requiring transplantation or resulting in high short-term mortality [2].
Ключевые слова
drug-induced liver injury; acetaminophen; HSP70; central nervous system; neurotoxicity; cellular stress response; experimental hepatitis.
Библиографические ссылки
- Aithal G.P., Watkins P.B., Andrade R.J., et al. Case definition and phenotype standardization in drug-induced liver injury // Clinical Gastroenterology and Hepatology. — 2023. — Vol. 21, No. 5. — P. 1234–1246. — DOI: 10.1016/j.cgh.2022.08.028
- Kaplowitz N. Drug-induced liver injury: update on mechanisms and risk factors // Hepatology. — 2021. — Vol. 73, No. 6. — P. 2486–2496. — DOI: 10.1002/hep.31514
- Lee W.M. Acute liver failure including drug-induced liver injury // Clinical Liver Disease. — 2022. — Vol. 19, No. 3. — P. 67–73. — DOI: 10.1002/cld.1225
- Polson J., Lee W.M. AASLD position paper: the management of acute liver failure and drug-induced liver injury // Hepatology Communications. — 2023. — Vol. 7, No. 4. — P. e1087–e1102. — DOI: 10.1002/hep4.2156
- Uetrecht J., Naisbitt D.J. Idiosyncratic drug-induced liver injury: current understanding and future directions // Nature Reviews Gastroenterology & Hepatology. — 2020. — Vol. 17, No. 7. — P. 431–442. — DOI: 10.1038/s41575-020-0297-4